SCHEMBL7689034

SCHEMBL7689034

O=C(CC(=O)C1CCC1)OCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
MAPK1 P28482 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
USP2 O75604 1/20 0.50
HPGD P15428 1/20 0.50
GAA P10253 1/20 0.50
TSHR P16473 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
CYP2C19 P33261 2/20 0.46
KMT2A Q03164 2/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
EPHX1 P07099 1/20 0.45
HTT P42858 1/20 0.44
MEN1 O00255 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8194806 0.97 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1USP2HPGD
SCHEMBL7700314 0.95 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1USP2HPGD
SCHEMBL7690148 0.94 ALDH1A1 (0.56) ALDH1A1MAPK1L3MBTL1GAATSHR
SCHEMBL3664444 0.80 TSHR (0.58) ALDH1A1MAPK1L3MBTL1USP2HPGD
SCHEMBL23518932 0.79 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1GAATSHR
SCHEMBL294341 0.79 ALDH1A1 (0.73) ALDH1A1MAPK1L3MBTL1SMN1; SMN2NPC1
SCHEMBL16321255 0.79 EPHX2 (0.52) ALDH1A1HPGDSMN1; SMN2NPC1RAB9A
SCHEMBL20954411 0.78 CYP19A1 (0.48) ALDH1A1GAAKMT2ACYP2C9
SCHEMBL20954379 0.78 KMT2A (0.45) ALDH1A1L3MBTL1GAASMN1; SMN2KMT2A
SCHEMBL7639964 0.78 FKBP1A (0.50) ALDH1A1MAPK1L3MBTL1USP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376521-B1 ANTIINFLAMMATORY AGENTS; ANTIISCHEMIC AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2002-04-23 US disclosed
WO-2000002861-A1 A3 ADENOSINE RECEPTOR ANTAGONISTS THE UNITED STATES OF AMERICA, REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-01-20 WO disclosed